Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Richard Rudick, M.D.
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...